Literature DB >> 4213697

Metabolic pathways of aprindine.

P J Murphy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4213697

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN： 0001-5385            Impact factor:   1.718


× No keyword cloud information.
  5 in total

1.  [Drug therapy of tachyarrhythmias (author's transl)].

Authors:  K Theisen
Journal:  Klin Wochenschr       Date:  1978-02-15

2.  Dose-dependent pharmacokinetics of aprindine in healthy volunteers.

Authors:  T Kobari; T Itoh; T Hirakawa; H Namekawa; T Suzuki; T Satoh; N Iida; F Ohtsu; H Hayakawa
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 3.  New antiarrhythmic drugs: their place in therapy.

Authors:  D L Keefe; R E Kates; D C Harrison
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

4.  The metabolism of aprindine in relation to the sparteine/debrisoquine polymorphism.

Authors:  T Ebner; M Eichelbaum
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

5.  Suppression of refractory arrhythmias by aprindine in patients with the Wolff-Parkinson-White syndrome.

Authors:  P R Reid; H L Greene; P J Varghese
Journal:  Br Heart J       Date:  1977-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.